Articles Tagged With: dapivirine
-
Results of HIV Vaginal Ring Study Demonstrate Adherence
Adherence to the dapivirine vaginal ring, a topical HIV-1 agent to prevent HIV infection, improved over time, according to the results of a recent study. The vaginal ring is an investigational pre-exposure prophylactic agent that is inserted in the vagina. The silicone matrix ring is loaded with a microbicidal agent. -
Researchers Release Initial Results on Developmental Vaginal Ring
In an effort to provide both HIV/AIDS and unintended pregnancy protection, researchers have developed a vaginal ring containing the antiretroviral drug dapivirine and the contraceptive hormone levonorgestrel. Scientists have just released results of an initial clinical trial, noting no safety issues.
-
2 studies show monthly vaginal ring protects women against HIV
Results presented at the 2016 Conference on Retroviruses and Opportunistic Infections from two large Phase III clinical trials suggest that a monthly vaginal ring containing the antiretroviral drug dapivirine (and no contraceptives) can safely help prevent HIV-1 infection in women.